530313 KIMIABL

Kimia Biosciences Share Price

₹43.00 +0.46 (1.08%)

16 Jan, 2025 13:01

SIP TrendupStart SIP in KIMIABL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -9.55%
  • Over 3 Month -13.57%
  • Over 6 Month -18.25%
  • Over 1 Year + 19.28%
SIP Lightning

Smart Investing Starts Here Start SIP with Kimia Biosciences for Steady Growth!

Invest Now

Kimia Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Kimia Biosciences Financials

Kimia Biosciences Technicals

EMA & SMA

Current Price
₹43.00
+ 0.46 (1.08%)
pointer
  • stock-down_img
  • Bearish Moving Average 14
  • stock-up_img
  • Bullish Moving Average 2
  • 20 Day
  • ₹44.50
  • 50 Day
  • ₹46.39
  • 100 Day
  • ₹47.71
  • 200 Day
  • ₹47.55

Resistance and Support

42.44 Pivot Speed
  • R3 43.64
  • R2 43.21
  • R1 42.87
  • S1 42.10
  • S2 41.67
  • S3 41.33

What's your outlook on Kimia Biosciences?

You can only vote for once

Kimia Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-06-28 Others
2024-05-30 Audited Results
2024-02-14 Quarterly Results

Kimia Biosciences F&O

Kimia Biosciences Shareholding Pattern

No data available.

About Kimia Biosciences

  • NSE Symbol
  • KIMIABL
  • BSE Symbol
  • 530313
  • ISIN
  • INE285U01025

Similar Stocks to Kimia Biosciences

Kimia Biosciences FAQs

Kimia Biosciences share price is ₹43 As on 16 January, 2025 | 12:47

The Market Cap of Kimia Biosciences is ₹203.4 Cr As on 16 January, 2025 | 12:47

The P/E ratio of Kimia Biosciences is 70.3 As on 16 January, 2025 | 12:47

The PB ratio of Kimia Biosciences is 615.2 As on 16 January, 2025 | 12:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23